Micah Riskin

Micah Riskin has extensive work experience in the pharmaceutical industry. They are currently working as the Director MSAT (Product Steward) at Actinium Pharmaceuticals, Inc. Prior to this, they worked as the Director/Lead MSAT at Imvax, Inc. From 2017 to 2021, Micah held various roles at Celgene, including Associate Director, Global MSAT and Principal Engineer, Global MSAT. They also worked at BioMarin Pharmaceutical Inc. as a Process Validation Manager, at MedImmune as a Sr. Manager, Quality Assurance Validation, at Bristol Myers Squibb as a Validation Engineering Manager, at ImClone Systems as a Senior Engineer, Validation Technical Services, and at Kvaerner Process as a Process Engineer.

Micah Riskin completed a Bachelor of Science in Chemical Engineering at Penn State University from 1995 to 1999. Subsequently, from 2006 to 2009, they pursued a Master of Business Administration (MBA) degree with a focus in Finance and Supply Chain Management at Rutgers University - Newark. Finally, from 2009 to 2016, Micah attended Penn State University again and obtained a Master's degree in Applied Statistics.